MA41506A - Procédés de production de virus pour produire des vaccins - Google Patents
Procédés de production de virus pour produire des vaccinsInfo
- Publication number
- MA41506A MA41506A MA041506A MA41506A MA41506A MA 41506 A MA41506 A MA 41506A MA 041506 A MA041506 A MA 041506A MA 41506 A MA41506 A MA 41506A MA 41506 A MA41506 A MA 41506A
- Authority
- MA
- Morocco
- Prior art keywords
- production processes
- virus production
- produce vaccines
- vaccines
- produce
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32311—Enterovirus
- C12N2770/32321—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32311—Enterovirus
- C12N2770/32334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32311—Enterovirus
- C12N2770/32351—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32311—Enterovirus
- C12N2770/32361—Methods of inactivation or attenuation
- C12N2770/32363—Methods of inactivation or attenuation by chemical treatment
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562116361P | 2015-02-13 | 2015-02-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA41506A true MA41506A (fr) | 2017-12-19 |
Family
ID=56615015
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA041506A MA41506A (fr) | 2015-02-13 | 2016-02-11 | Procédés de production de virus pour produire des vaccins |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20180195048A1 (fr) |
| EP (1) | EP3256571B1 (fr) |
| JP (1) | JP6723253B2 (fr) |
| KR (1) | KR20170116140A (fr) |
| CN (2) | CN114107221A (fr) |
| AU (2) | AU2016219122A1 (fr) |
| CA (1) | CA2975881A1 (fr) |
| HK (1) | HK1248759A1 (fr) |
| MA (1) | MA41506A (fr) |
| PH (1) | PH12017501445A1 (fr) |
| SG (1) | SG11201706593SA (fr) |
| WO (1) | WO2016130940A1 (fr) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11008547B2 (en) | 2014-03-25 | 2021-05-18 | Terumo Bct, Inc. | Passive replacement of media |
| WO2017004592A1 (fr) | 2015-07-02 | 2017-01-05 | Terumo Bct, Inc. | Croissance cellulaire à l'aide de stimuli mécaniques |
| AU2017254665C1 (en) | 2016-04-20 | 2021-03-11 | Centro de Investigaciones Energeticas, Medioambientales Y Tecnologicas, O.A., M.P. | Compositions and methods for enhanced gene expression of PKLR |
| US11965175B2 (en) | 2016-05-25 | 2024-04-23 | Terumo Bct, Inc. | Cell expansion |
| US11685883B2 (en) | 2016-06-07 | 2023-06-27 | Terumo Bct, Inc. | Methods and systems for coating a cell growth surface |
| US11104874B2 (en) | 2016-06-07 | 2021-08-31 | Terumo Bct, Inc. | Coating a bioreactor |
| CN109689092A (zh) * | 2016-09-01 | 2019-04-26 | 武田疫苗股份有限公司 | 用于产生用于疫苗生产的病毒的方法 |
| BE1024733B1 (fr) | 2016-11-09 | 2018-06-14 | Univercells Sa | Matrice de croissance cellulaire |
| KR102091372B1 (ko) * | 2017-02-28 | 2020-05-27 | 대한민국 | 엔테로바이러스 71형 불활화 백신 및 이의 용도 |
| US11629332B2 (en) | 2017-03-31 | 2023-04-18 | Terumo Bct, Inc. | Cell expansion |
| RU2020114891A (ru) | 2017-09-27 | 2021-10-27 | Юниверселлс С.А. | Система и способ получения биомолекул, таких как вирусные вакцины |
| CN111801410A (zh) | 2017-12-20 | 2020-10-20 | 尤尼沃尔塞尔斯技术股份公司 | 生物反应器及相关方法 |
| CN119629335A (zh) | 2018-05-14 | 2025-03-14 | 交互数字Vc控股公司 | 用于视频编解码的方法、设备、装置、介质和程序产品 |
| CA3123449A1 (fr) * | 2018-12-21 | 2020-06-25 | Lonza Walkersville, Inc. | Production automatisee de vecteurs viraux |
| US11692161B2 (en) | 2019-02-05 | 2023-07-04 | Corning Incorporated | Packed-bed bioreactor systems and methods of using the same |
| JP7548916B2 (ja) * | 2019-02-15 | 2024-09-10 | オロジー バイオサーヴィシズ、インク． | ウイルスの製造方法 |
| US11118151B2 (en) | 2019-11-05 | 2021-09-14 | Corning Incorporated | Fixed bed bioreactor and methods of using the same |
| KR102696955B1 (ko) * | 2019-11-27 | 2024-08-19 | 에스케이바이오사이언스(주) | 무혈청 배지에서 부유배양이 가능한 신규한 Vero 세포주, 이의 제조 방법 및 상기 신규 세포주를 이용한 백신용 바이러스 제조 방법 |
| KR20230019450A (ko) * | 2020-05-29 | 2023-02-08 | 온코루스, 인크. | 캡슐화된 rna 레플리콘 및 사용 방법 |
| CN111849870B (zh) * | 2020-08-07 | 2021-07-23 | 成都柏奥特克生物科技股份有限公司 | 无血清Vero细胞固定床生物反应器高密度培养工艺 |
| CN116829180A (zh) * | 2020-10-23 | 2023-09-29 | 弹性政府服务公司 | 用于用病毒感染细胞的方法 |
| WO2022125793A1 (fr) * | 2020-12-10 | 2022-06-16 | Sarepta Therapeutics, Inc. | Multiplication par séries de semences en mode suspension pour cellules adhérentes |
| CN114990075B (zh) * | 2022-04-20 | 2023-07-14 | 中国医学科学院医学生物学研究所 | 一株可适用于人用疫苗细胞基质培养的柯萨奇病毒a组10型疫苗株及其应用 |
| CN114807060B (zh) * | 2022-06-23 | 2022-09-30 | 北京民海生物科技有限公司 | 柯萨奇病毒a6型毒株及其免疫原性组合物和应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7494659B2 (en) * | 2000-09-25 | 2009-02-24 | Polymun Scientific Immunbiologische Forschung Gmbh | Live attenuated influenza vaccine |
| US9051361B2 (en) * | 2010-08-17 | 2015-06-09 | National Health Research Institutes | Immunogenic compositions and uses thereof |
| WO2014112945A1 (fr) * | 2013-01-18 | 2014-07-24 | Temasek Life Sciences Laboratory Limited | Souches d'entérovirus 71 sensibles à la température, adaptées au froid, et procédés de développement de souches virales sensibles à la température, adaptées au froid |
| CN103215233B (zh) * | 2013-04-03 | 2015-03-25 | 浙江普康生物技术股份有限公司 | 用生物反应器扩增肠道病毒71型的优化工艺方法 |
-
2016
- 2016-02-11 MA MA041506A patent/MA41506A/fr unknown
- 2016-02-12 JP JP2017542081A patent/JP6723253B2/ja not_active Expired - Fee Related
- 2016-02-12 AU AU2016219122A patent/AU2016219122A1/en not_active Abandoned
- 2016-02-12 CA CA2975881A patent/CA2975881A1/fr not_active Abandoned
- 2016-02-12 SG SG11201706593SA patent/SG11201706593SA/en unknown
- 2016-02-12 EP EP16749976.3A patent/EP3256571B1/fr active Active
- 2016-02-12 US US15/550,718 patent/US20180195048A1/en not_active Abandoned
- 2016-02-12 CN CN202111316202.3A patent/CN114107221A/zh active Pending
- 2016-02-12 KR KR1020177025598A patent/KR20170116140A/ko not_active Ceased
- 2016-02-12 WO PCT/US2016/017784 patent/WO2016130940A1/fr not_active Ceased
- 2016-02-12 CN CN201680015584.7A patent/CN107532150A/zh active Pending
- 2016-02-12 HK HK18108353.4A patent/HK1248759A1/zh unknown
-
2017
- 2017-08-10 PH PH12017501445A patent/PH12017501445A1/en unknown
-
2022
- 2022-03-28 AU AU2022202087A patent/AU2022202087A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP3256571A4 (fr) | 2018-07-25 |
| KR20170116140A (ko) | 2017-10-18 |
| PH12017501445A1 (en) | 2018-01-15 |
| JP2018506283A (ja) | 2018-03-08 |
| SG11201706593SA (en) | 2017-09-28 |
| HK1248759A1 (zh) | 2018-10-19 |
| WO2016130940A1 (fr) | 2016-08-18 |
| EP3256571B1 (fr) | 2022-03-30 |
| CN114107221A (zh) | 2022-03-01 |
| CN107532150A (zh) | 2018-01-02 |
| CA2975881A1 (fr) | 2016-08-18 |
| JP6723253B2 (ja) | 2020-07-15 |
| AU2022202087A1 (en) | 2022-04-14 |
| US20180195048A1 (en) | 2018-07-12 |
| AU2016219122A1 (en) | 2017-09-07 |
| EP3256571A1 (fr) | 2017-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA41506A (fr) | Procédés de production de virus pour produire des vaccins | |
| ZA201903906B (en) | Phosphoramidates for the treatment of hepatitis b virus | |
| SG11201707663SA (en) | Lyophilization of rna | |
| EP3364949A4 (fr) | Vaccins anticancéreux | |
| IL256499A (en) | Antibodies to CD40 | |
| IL255880B (en) | Processes for the manufacture of bivaracetam | |
| HUE059158T2 (hu) | Eljárás pridopidin elõállítására | |
| SG11201608605QA (en) | Methods and means for enhancing rna production | |
| MA52906A (fr) | Procédé de préparation d'amg 416 | |
| SG10201911996RA (en) | Process to produce modified clay, modified clay produced and use thereof | |
| HUE050974T2 (hu) | Eljárás pirimidinszulfamid-származékok elõállítására | |
| GB201521581D0 (en) | Methods of purifying nanostructures | |
| ZA201700254B (en) | Process for the preparation of 4-alkoxy-3-hydroxypicolinic acids | |
| EP3265120C0 (fr) | Procédé | |
| SG11201607098SA (en) | Antibody purification process | |
| HUE049170T2 (hu) | Eljárás szubsztituált cikloszerinek elõállítására | |
| HUE047756T2 (hu) | Eljárás metil-merkaptán elõállítására | |
| SG11201608513WA (en) | Novel purification process of gonadotropin | |
| SG11201802755WA (en) | Process for purification of methyl methacrylate | |
| LT3155004T (lt) | Vakcina, skirta asmeniui su sutrikusiu imunitetu | |
| EP3217965C0 (fr) | Proces pharmaceutique | |
| FR3024729B1 (fr) | Procede de preparation du trioxane | |
| MA42658A (fr) | Procédé de réduction de pathogènes | |
| EP3119573C0 (fr) | Procédé de préparation de béton | |
| KR102150179B9 (ko) | 나트륨 시아나이드의 제조 방법 |